Ochsner Health is the leading nonprofit healthcare provider in the Gulf South. Ochsner inspires healthier lives and stronger communities through our mission to serve, heal, lead, educate and innovate.
Healthcare is rapidly changing, presenting challenges to new physicians and the organizations that train them.
The rise of AI, new technologies, patient demands and increased awareness in social determinants of health and equity have pushed leaders and organizations to change how they evaluate healthcare workers' preparedness as they enter the field. In many cases — when addressing equity, for example — physicians are not always trained in how to address or screen for these issues.
These needs are fueling a push to update how medical schools train physicians for the future of healthcare. Some systems have already started making changes.
Change is coming, but here are a few more urgent needs for medical education that deserve focus, according to five leaders who connected with Becker's:
Ochsner Ventures has announced the creation of the Ochsner Louisiana Innovation Fund, a $10 million fund for investments in early-stage, innovative health and health-adjacent companies in Louisiana.
VIEW THIS ARTICLE ON Biz New OrleansBecker's asked C-suite executives from hospitals and health systems across the U.S. to share their focus for the remainder of the year.
VIEW THIS ARTICLE ON Becker's Hospital ReviewTo recognize such hospitals, U.S. News developed a methodology defining the 2024-2025 Best Regional Hospitals for Equitable Access. The resulting list of 98 hospitals – published here for the first time – expands on a smaller group of hospitals recognized last month. Hospitals on this expanded list were recognized for excellent performance in both quality and measures related to access to care for historically underserved communities.
VIEW THIS ARTICLE ON U.S. News & World ReportFor the 13th consecutive year, Ochsner Medical Center - New Orleans (OMC), inclusive of Ochsner Medical Center- West Bank and Ochsner Baptist, has been named by U.S. News & World Report to its 2024-2025 Best Hospitals, ranking as the Best Hospital in Louisiana and the No. 1 hospital in the New Orleans metro area.
VIEW THIS ARTICLE ON The Associated PressEighty-eight New Orleans-area companies were recently honored as part of The Times-Picayune’s annual program to determine the top places to work across the region.
VIEW THIS ARTICLE ON The Times-PicayuneMuch is expected of the new Xavier Ochsner College of Medicine. Also known as XOCOM, the school aims to help alleviate Louisiana’s severe physician shortage, boost diversity in the physician workforce, reduce health inequities and revitalize downtown New Orleans.
The new institution, a collaborative effort between Ochsner Health and Xavier University of Louisiana, does not have a projected opening date. That will come after it earns accreditation from the Liaison Committee on Medical Education (LCME), which is typically a three- to five-year process. But it does have a location, the 26-story Benson Tower, which already houses Ochsner Health’s administrative offices.
And a founding dean has been named, Leonardo Seoane, MD, executive vice president and chief academic officer at Ochsner Health.
VIEW THIS ARTICLE ON American Medical AssociationBecker's "Hospitals and Health Systems with Great Heart Programs" list showcases healthcare institutions celebrated for their outstanding cardiovascular care, superior patient outcomes and advanced technologies. These heart programs are also at the forefront of cardiology research, making impactful discoveries in the field.
VIEW THIS ARTICLE ON Becker's Hospital ReviewU.S. News & World Report announced the 2024-25 "Best Hospitals" rankings and ratings on July 16, which evaluated the performance of nearly 5,000 hospitals on measures such as risk-adjusted mortality rates, preventable complications and level of nursing care.
VIEW THIS ARTICLE ON Becker's Hospital ReviewIn the last year, the field of oncology has continued to grapple with significant challenges that have imposed formidable hurdles on cancer care worldwide.
Unforeseen disruptions in the pharmaceutical supply chain, compounded by increased demand and complex manufacturing processes, have contributed to a scarcity of crucial medications essential for cancer treatment. As early as May 2023, a litany of publications from NBC News, NPR, and The New York Times gained national attention regarding oncology medication shortages.
Further, The White House intervened, taking action to improve access to carboplatin, 5-fluorouracil and methotrexate. These shortages primarily encompassed first-line therapies, leaving oncology providers with limited options and potentially compromising patient outcomes.
VIEW THIS ARTICLE ON Becker's Hospital Review